STAAR Surgical Company Company Profile (NASDAQ:STAA)

About STAAR Surgical Company (NASDAQ:STAA)

STAAR Surgical Company logoSTAAR Surgical Company designs, develops, manufactures and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. It operates in the ophthalmic surgical market segment. Its principal products are intraocular lenses used in cataract surgery and implantable collamer lenses used in refractive surgery. It makes lenses used across the world in corrective or refractive surgery, and makes lenses for use in surgery that treats cataracts. Its refractive surgery corrects the types of visual disorders that glasses or contact lenses have treated (myopia, hyperopia, astigmatism and presbyopia). Its refractive surgery corrects the types of visual disorders that glasses or contact lenses have treated (myopia, hyperopia, astigmatism and presbyopia). As of December 30, 2016, it sold its products in more than 60 countries, with direct distribution in the United States, Canada, Japan and Spain, and independent distribution in the remainder of the world.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Medical Equipment, Supplies & Distribution - NEC
  • Sub-Industry: Health Care Supplies
  • Symbol: NASDAQ:STAA
  • CUSIP: 85231230
  • Web:
  • Market Cap: $417.7 million
  • Outstanding Shares: 40,932,000
Average Prices:
  • 50 Day Moving Avg: $10.14
  • 200 Day Moving Avg: $9.90
  • 52 Week Range: $6.34 - $11.50
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: 113.33
  • P/E Growth: -2.75
Sales & Book Value:
  • Annual Revenue: $83.51 million
  • Price / Sales: 5.00
  • Book Value: $0.90 per share
  • Price / Book: 11.33
  • EBIDTA: ($1,640,000.00)
  • Net Margins: -7.53%
  • Return on Equity: -10.83%
  • Return on Assets: -6.21%
  • Debt-to-Equity Ratio: 0.04%
  • Current Ratio: 2.25%
  • Quick Ratio: 1.58%
  • Average Volume: 86,360 shs.
  • Beta: 1.3
  • Short Ratio: 18.14
Frequently Asked Questions for STAAR Surgical Company (NASDAQ:STAA)

What is STAAR Surgical Company's stock symbol?

STAAR Surgical Company trades on the NASDAQ under the ticker symbol "STAA."

How were STAAR Surgical Company's earnings last quarter?

STAAR Surgical Company (NASDAQ:STAA) released its quarterly earnings data on Wednesday, May, 3rd. The company reported ($0.05) EPS for the quarter, beating the Thomson Reuters' consensus estimate of ($0.05) by $0.00. The firm had revenue of $20.35 million for the quarter. STAAR Surgical Company had a negative net margin of 7.53% and a negative return on equity of 10.83%. During the same quarter in the prior year, the firm earned ($0.20) earnings per share. View STAAR Surgical Company's Earnings History.

When will STAAR Surgical Company make its next earnings announcement?

STAAR Surgical Company is scheduled to release their next quarterly earnings announcement on Wednesday, August, 2nd 2017. View Earnings Estimates for STAAR Surgical Company.

Where is STAAR Surgical Company's stock going? Where will STAAR Surgical Company's stock price be in 2017?

3 brokers have issued 12-month price objectives for STAAR Surgical Company's stock. Their forecasts range from $9.00 to $12.00. On average, they anticipate STAAR Surgical Company's share price to reach $10.50 in the next year. View Analyst Ratings for STAAR Surgical Company.

Who are some of STAAR Surgical Company's key competitors?

Who are STAAR Surgical Company's key executives?

STAAR Surgical Company's management team includes the folowing people:

  • Caren L. Mason, President, Chief Executive Officer, Director
  • Deborah J. Andrews, Vice President, Interim Chief Financial Officer
  • Hans-Martin Blickensdoerfer, Senior Vice President - Commercial Operations for Europe, Middle East, Africa, Latin America and China.
  • James E. Francese, Senior Vice President of North American and APAC
  • Keith Holliday Ph.D., Chief Technology Officer, Vice President
  • William Walter Goodmen, Vice President - Global Human Resources
  • Jon K. Hayashida, Vice President - Global Clinical and Medical Affairs
  • Philippe Subrin, Vice President-ICL Manufacturing
  • Samuel J. Gesten, Vice President - Business Development, Chief Legal Officer and Secretary
  • Denise McEachern, Global Head of Regulatory Affairs and Quality Assurance

Who owns STAAR Surgical Company stock?

STAAR Surgical Company's stock is owned by a variety of of retail and institutional investors. Top institutional investors include Creative Planning (0.08%), Strs Ohio (0.07%), Campbell & CO Investment Adviser LLC (0.06%), Public Employees Retirement Association of Colorado (0.05%), Bollard Group LLC (0.04%) and Simplex Trading LLC (0.03%). Company insiders that own STAAR Surgical Company stock include Broadwood Partners Lp, Caren L Mason, Hans-Martin Blickensdoerfer and Richard A Meier. View Institutional Ownership Trends for STAAR Surgical Company.

Who bought STAAR Surgical Company stock? Who is buying STAAR Surgical Company stock?

STAAR Surgical Company's stock was acquired by a variety of institutional investors in the last quarter, including Campbell & CO Investment Adviser LLC, Simplex Trading LLC, Creative Planning and Strs Ohio. Company insiders that have bought STAAR Surgical Company stock in the last two years include Broadwood Partners Lp and Caren L Mason. View Insider Buying and Selling for STAAR Surgical Company.

How do I buy STAAR Surgical Company stock?

Shares of STAAR Surgical Company can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is STAAR Surgical Company's stock price today?

One share of STAAR Surgical Company stock can currently be purchased for approximately $10.20.

MarketBeat Community Rating for STAAR Surgical Company (NASDAQ STAA)
Community Ranking:  1.5 out of 5 ( )
Outperform Votes:  63 (Vote Outperform)
Underperform Votes:  144 (Vote Underperform)
Total Votes:  207
MarketBeat's community ratings are surveys of what our community members think about STAAR Surgical Company and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for STAAR Surgical Company (NASDAQ:STAA) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 2 Hold Ratings, 1 Buy Rating
Consensus Rating:Hold (Score: 2.33)
Consensus Price Target: $10.50 (2.94% upside)

Analysts' Ratings History for STAAR Surgical Company (NASDAQ:STAA)
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
7/11/2017Canaccord GenuityReiterated RatingHoldLowView Rating Details
3/3/2017Benchmark Co.Reiterated RatingBuy -> Buy$10.00 -> $12.00N/AView Rating Details
8/4/2016William BlairReiterated RatingMarket PerformN/AView Rating Details
5/12/2016StephensDowngradeOverweight -> Equal WeightN/AView Rating Details
(Data available from 7/27/2015 forward)


Earnings History for STAAR Surgical Company (NASDAQ:STAA)
Earnings by Quarter for STAAR Surgical Company (NASDAQ:STAA)
Earnings History by Quarter for STAAR Surgical Company (NASDAQ STAA)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
8/2/2017N/AView Earnings Details
5/3/2017Q1 2017($0.05)($0.05)$20.35 millionViewListenView Earnings Details
3/2/2017Q4 2016($0.02)$0.02$22.25 million$22.10 millionViewListenView Earnings Details
11/3/2016Q316($0.04)($0.02)$20.70 million$20.05 millionViewListenView Earnings Details
8/3/2016Q216($0.05)($0.05)$19.88 million$21.00 millionViewListenView Earnings Details
5/11/2016Q116($0.17)($0.01)$19.60 million$19.30 millionViewListenView Earnings Details
3/2/2016Q415($0.02)$0.01$19.11 million$20.90 millionViewListenView Earnings Details
10/28/2015Q315($0.04)($0.04)$17.87 million$18.80 millionViewListenView Earnings Details
4/29/2015Q115($0.04)$0.03$17.85 million$18.90 millionViewListenView Earnings Details
2/25/2015Q414($0.05)($0.03)$16.60 million$16.60 millionViewListenView Earnings Details
10/30/2014Q314$0.02($0.04)$19.53 million$18.20 millionViewListenView Earnings Details
7/30/2014Q214$0.03$0.01$19.80 million$20.05 millionViewListenView Earnings Details
4/28/2014Q114$0.01$0.04$19.44 million$20.20 millionViewListenView Earnings Details
2/26/2014Q413$0.02$0.02$18.98 million$18.90 millionViewListenView Earnings Details
10/30/2013Q313$0.02$0.04$17.35 million$17.10 millionViewListenView Earnings Details
7/31/2013Q2 2013$0.04$0.05$17.40 million$18.20 millionViewListenView Earnings Details
5/1/2013Q1 2013$0.04$0.08$17.27 million$18.00 millionViewListenView Earnings Details
2/27/2013Q4 2012$0.03$0.01$17.55 million$16.50 millionViewListenView Earnings Details
10/31/2012Q312$0.01$0.04$16.78 million$15.90 millionViewN/AView Earnings Details
8/1/2012$0.03$0.03ViewN/AView Earnings Details
5/2/2012$0.03$0.04ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for STAAR Surgical Company (NASDAQ:STAA)
Current Year EPS Consensus Estimate: $-0.05 EPS
Next Year EPS Consensus Estimate: $0.09 EPS


Dividend History for STAAR Surgical Company (NASDAQ:STAA)
No dividend announcements for this company have been tracked by

Insider Trades

Insider Trading and Institutional Ownership History for STAAR Surgical Company (NASDAQ:STAA)
Insider Ownership Percentage: 5.60%
Institutional Ownership Percentage: 75.73%
Insider Trades by Quarter for STAAR Surgical Company (NASDAQ:STAA)
Institutional Ownership by Quarter for STAAR Surgical Company (NASDAQ:STAA)
Insider Trades by Quarter for STAAR Surgical Company (NASDAQ:STAA)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
12/9/2016Hans-Martin BlickensdoerferVPSell25,000$11.14$278,500.00View SEC Filing  
6/29/2016Broadwood Partners LpMajor ShareholderBuy14,144$5.24$74,114.56View SEC Filing  
5/25/2016Broadwood Partners LpMajor ShareholderBuy77,842$5.16$401,664.72View SEC Filing  
5/24/2016Broadwood Partners LpMajor ShareholderBuy70,000$5.16$361,200.00View SEC Filing  
5/23/2016Broadwood Partners LpMajor ShareholderBuy3,138$5.24$16,443.12View SEC Filing  
5/20/2016Richard A MeierDirectorSell25,000$5.35$133,750.00View SEC Filing  
5/17/2016Broadwood Partners LpMajor ShareholderBuy9,313$5.23$48,706.99View SEC Filing  
5/16/2016Broadwood Partners LpMajor ShareholderBuy336,210$5.49$1,845,792.90View SEC Filing  
2/9/2016Broadwood Partners LpMajor ShareholderBuy91,770$6.25$573,562.50View SEC Filing  
2/3/2016Broadwood Partners LpMajor ShareholderBuy121,599$6.40$778,233.60View SEC Filing  
2/1/2016Broadwood Partners LpMajor ShareholderBuy65,983$6.48$427,569.84View SEC Filing  
1/27/2016Broadwood Partners LpMajor ShareholderBuy239,013$6.63$1,584,656.19View SEC Filing  
1/26/2016Broadwood Partners LpMajor ShareholderBuy112,900$6.60$745,140.00View SEC Filing  
1/25/2016Broadwood Partners LpMajor ShareholderBuy81,752$6.74$551,008.48View SEC Filing  
1/20/2016Broadwood Partners LpMajor ShareholderBuy72,858$6.75$491,791.50View SEC Filing  
1/15/2016Broadwood Partners LpMajor ShareholderBuy135,725$6.73$913,429.25View SEC Filing  
1/11/2016Broadwood Partners LpMajor ShareholderBuy86,586$6.83$591,382.38View SEC Filing  
1/7/2016Broadwood Partners LpMajor ShareholderBuy267,047$6.95$1,855,976.65View SEC Filing  
1/4/2016Broadwood Partners LpMajor ShareholderBuy165,461$7.11$1,176,427.71View SEC Filing  
9/29/2015Broadwood Partners LpMajor ShareholderBuy311,099$7.08$2,202,580.92View SEC Filing  
8/25/2015Broadwood Partners LpMajor ShareholderBuy188,881$7.17$1,354,276.77View SEC Filing  
8/24/2015Caren L MasonCEOBuy10,000$7.34$73,400.00View SEC Filing  
4/6/2015Samuel J GestenVPSell3,223$7.14$23,012.22View SEC Filing  
3/3/2015Robin HughesVPSell23,253$15.82$367,862.46View SEC Filing  
11/19/2014Broadwood Partners LpMajor ShareholderBuy189,646$8.64$1,638,541.44View SEC Filing  
11/18/2014Broadwood Partners LpMajor ShareholderBuy39,400$8.67$341,598.00View SEC Filing  
11/17/2014Broadwood Partners LpMajor ShareholderBuy118,200$8.63$1,020,066.00View SEC Filing  
11/10/2014Broadwood Partners LpMajor ShareholderBuy500$8.79$4,395.00View SEC Filing  
11/7/2014Broadwood Partners LpMajor ShareholderBuy80,000$8.92$713,600.00View SEC Filing  
11/4/2014Broadwood Partners LpMajor ShareholderBuy260,341$9.20$2,395,137.20View SEC Filing  
5/15/2014John MooreDirectorSell2,800$14.87$41,636.00View SEC Filing  
3/19/2014James FranceseVPSell16,666$17.22$286,988.52View SEC Filing  
3/17/2014Robin HughesVPSell5,672$16.61$94,211.92View SEC Filing  
9/4/2013Deborah AndrewsCFOSell50,000$12.88$644,000.00View SEC Filing  
8/20/2013Deborah AndrewsCFOSell33,515$11.65$390,449.75View SEC Filing  
8/12/2013Deborah AndrewsCFOSell9,079$11.62$105,497.98View SEC Filing  
8/7/2013Deborah AndrewsCFOSell11,721$11.79$138,190.59View SEC Filing  
5/9/2013Deborah J AndrewsCFOSell5,000$8.96$44,800.00View SEC Filing  
12/11/2012John C MooreDirectorBuy5,000$5.46$27,300.00View SEC Filing  
11/15/2012Broadwood Partners LpMajor ShareholderBuy2,618$5.00$13,090.00View SEC Filing  
11/15/2012Mark B LoganDirectorBuy3,600$5.22$18,792.00View SEC Filing  
11/14/2012Barry G CaldwellCEOBuy5,000$5.04$25,200.00View SEC Filing  
11/2/2012Broadwood Partners LpMajor ShareholderBuy22,572$5.00$112,860.00View SEC Filing  
8/9/2012Barry G CaldwellCEOBuy5,000$6.57$32,850.00View SEC Filing  
(Data available from 1/1/2013 forward)


Headline Trends for STAAR Surgical Company (NASDAQ:STAA)
Latest Headlines for STAAR Surgical Company (NASDAQ:STAA)
DateHeadline logoSTAAR Surgical to Report Second Quarter Results on August 2, 2017 - July 20 at 8:08 AM logoSTAAR Surgical Company (STAA) Rating Increased to Hold at Zacks Investment Research - July 5 at 11:00 AM logoZacks: STAAR Surgical Company (STAA) Given $12.00 Consensus Price Target by Brokerages - June 22 at 6:42 PM logoStaar Surgical to pay $7 million in investor suit over FDA violations - June 22 at 1:50 PM logoSTAAR Surgical Co. – Value Analysis (NASDAQ:STAA) : June 19, 2017 - June 20 at 8:13 AM logoSTAAR Surgical Co. breached its 50 day moving average in a Bullish Manner : STAA-US : June 16, 2017 - June 17 at 6:25 AM logoReviewing Inogen (INGN) and STAAR Surgical Company (STAA) - June 14 at 7:50 AM logoSTAAR Surgical Co. breached its 50 day moving average in a Bearish Manner : STAA-US : May 22, 2017 - May 22 at 8:49 AM logoSTAAR Surgical Announces CE Mark Approval for the EVO+ Visian ICL with Aspheric (EDOF) Optic - May 11 at 9:57 PM logoSTAAR Surgical Co. breached its 50 day moving average in a Bearish Manner : STAA-US : May 10, 2017 - May 10 at 10:34 AM logoSTAAR Surgical Company (STAA) Cut to "Sell" at Zacks Investment Research - May 9 at 11:00 AM logoETFs with exposure to STAAR Surgical Co. : May 8, 2017 - May 8 at 7:32 PM logoSTAAR Surgical Company (STAA) Forecasted to Earn FY2017 Earnings of ($0.05) Per Share - May 8 at 9:38 AM logoSTAAR Surgical Co. :STAA-US: Earnings Analysis: Q1, 2017 By the Numbers : May 5, 2017 - May 6 at 10:03 AM logoSTAAR Surgical Company (STAA) Announces Earnings Results - May 5 at 10:47 PM logoSTAAR Surgical Company Forecasted to Post FY2018 Earnings of $0.09 Per Share (STAA) - May 5 at 6:52 PM logoSomewhat Favorable Media Coverage Very Likely to Affect STAAR Surgical Company (STAA) Stock Price - May 4 at 9:14 PM logoEdited Transcript of STAA earnings conference call or presentation 3-May-17 8:30pm GMT - May 4 at 8:55 PM logoEARNINGS SUMMARY: Details of STAAR Surgical Company Q1 Earnings Report - May 3 at 6:12 PM logoBRIEF-Staar Surgical reports Q1 sales $20.4 million - May 3 at 6:12 PM logoSTAAR Surgical Reports First Quarter 2017 Results - May 3 at 6:12 PM logoStaar Surgical reports 1Q loss - May 3 at 6:12 PM logoInvestor Network: STAAR Surgical Company to Host Earnings Call - May 3 at 10:37 AM logoPositive Media Coverage Somewhat Unlikely to Impact STAAR Surgical Company (STAA) Stock Price - April 29 at 10:47 PM logoSTAAR Surgical Co. – Value Analysis (NASDAQ:STAA) : April 27, 2017 - April 27 at 8:24 PM logoSTAAR Surgical Co. breached its 50 day moving average in a Bullish Manner : STAA-US : April 26, 2017 - April 26 at 9:09 AM logoSTAAR Surgical to Report First Quarter Results on May 3, 2017 - April 24 at 11:20 AM logoSTAAR Surgical Company (STAA) Earning Somewhat Critical News Coverage, Report Shows - April 23 at 3:13 PM logoSomewhat Critical News Coverage Very Likely to Affect STAAR Surgical Company (STAA) Stock Price - April 20 at 8:53 AM logoSTAAR Surgical Company (STAA) Receives News Impact Score of 0.31 - April 14 at 8:25 PM logoCFO Moves: Varian Medical Systems, STAAR Surgical, Federated National Holding, Daily Mail & General Trust - April 7 at 12:48 PM logoSTAAR Surgical Names Deborah Andrews Interim CFO - April 7 at 12:48 PM logo STAAR Surgical Company (STAA) Given $6.00 Average Price Target by Brokerages - March 30 at 12:01 PM logoSTAAR Surgical Company (STAA) Price Target Raised to $12.00 - March 9 at 7:36 AM logoSTAAR SURGICAL CO Financials - March 8 at 8:21 PM logoSTAAR SURGICAL CO Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits - March 3 at 8:01 PM logoSTAAR Surgical's (STAA) CEO Caren Mason on Q4 2016 Results - Earnings Call Transcript - March 2 at 8:08 PM logoSTAAR Surgical Company Q4 Income Climbs 46% - March 2 at 8:08 PM logoBRIEF-Staar Surgical Q4 adjusted earnings per share $0.02 - March 2 at 8:08 PM logoQ4 2016 STAAR Surgical Co Earnings Release - After Market Close - March 2 at 8:08 PM logoSTAAR Surgical Reports Fourth Quarter 2016 Results - March 2 at 8:08 PM logo4:04 pm STAAR Surgical reports EPS in-line, revs in-line - March 2 at 8:08 PM logoSTAAR SURGICAL CO Files SEC form 8-K, Results of Operations and Financial Condition - March 2 at 8:08 PM logoNorth America Ophthalmology Cataract Surgery Devices Market - Opportunities and Forecasts, 2014 - 2022 - Research and Markets - February 22 at 10:05 AM logoSTAAR Surgical to Report Fourth Quarter Results on March 2, 2017 - February 16 at 7:47 PM logoForm 8-K STAAR SURGICAL CO For: Jan 10 - January 12 at 1:24 AM



STAAR Surgical Company (STAA) Chart for Thursday, July, 27, 2017

This page was last updated on 7/27/2017 by Staff